牛血清白蛋白市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、應用、地區和競爭細分，2020-2030 年）

2024 年全球牛血清白蛋白市場價值為 56.2 億美元，預計在預測期內將呈現強勁成長，到 2030 年的複合年成長率為 8.02%。全球牛血清白蛋白市場是更廣泛的生物技術和製藥行業中一個充滿活力且快速發展的行業。牛血清白蛋白 (BSA) 是一種從牛血清中提取的多功能蛋白質，在各個科學和研究領域有著廣泛的應用。該市場涵蓋 BSA 的生產、分銷和利用，服務於廣泛的最終用戶，包括學術和研究機構、製藥公司、生物技術公司和診斷實驗室。例如，根據美國國家醫學圖書館的數據，2022 年全球共進行了 3.1 億次大型手術。其中，約有 4,000 萬至 5,000 萬次在美國進行，而約有 2,000 萬次在歐洲進行。這凸顯了全球對外科手術的巨大需求，其中美國和歐洲佔了總量的很大一部分。

推動全球牛血清白蛋白市場成長的關鍵因素包括其在細胞培養和各種生化測定中的重要作用、其在各種診斷和治療產品中作為穩定劑的用途、以及其在製藥和生物技術領域日益成長的需求。 BSA是細胞培養基中的關鍵成分，提供必需的營養物質、生長因子和緩衝能力，從而促進細胞生長和蛋白質生產，使其成為生物加工中不可或缺的物質。

關鍵市場促進因素

不斷發展的生物製藥產業

主要市場挑戰

倫理問題和替代來源

主要市場趨勢

細胞培養應用的擴展

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：全球牛血清白蛋白市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 副產物（人血清白蛋白、牛血清白蛋白、重組血清白蛋白）
  • 依應用（治療、藥物傳輸、培養基、疫苗成分、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖
  • 按產品
  • 按應用
  • 按地區

第5章：亞太地區牛血清白蛋白市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按產品
  • 按應用
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第6章：歐洲牛血清白蛋白市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 西班牙
  • 義大利
  • 英國

第7章：北美牛血清白蛋白市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 墨西哥
  • 加拿大

第8章：南美牛血清白蛋白市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第9章：中東和非洲牛血清白蛋白市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：市場動態

• 驅動程式
• 挑戰

第 11 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第 12 章：全球牛血清白蛋白市場：SWOT 分析

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc (US)
• Merck KGAA (Germany)
• Itoham Yonekyu Holdings Inc (Japan)
• Proliant Biologicals (US)
• Kraeber & Co Gmbh (Germany)
• Rockland Immunochemicals Inc (US)
• Rocky mountain biologicals (US)
• BelHealth investment partners, LLC (US)
• Bio-Techne Corporation (US)

第15章：戰略建議

第16章調查會社について,免責事項

Global Bovine Serum Albumin Market was valued at USD 5.62 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 8.02% through 2030. The global bovine serum albumin market is a dynamic and rapidly evolving sector within the broader biotechnology and pharmaceutical industry. Bovine serum albumin (BSA) is a versatile protein derived from cow's blood serum and has found extensive applications across various scientific and research fields. This market encompasses the production, distribution, and utilization of BSA, serving a wide range of end-users, including academic and research institutions, pharmaceutical companies, biotechnology firms, and diagnostic laboratories. For instance, according to the National Library of Medicine, a total of 310 million major surgeries were conducted worldwide in 2022. Of these, approximately 40-50 million took place in the U.S., while around 20 million were performed across Europe. This highlights the significant global demand for surgical procedures, with the U.S. and Europe comprising a substantial portion of the total volume.

Key factors driving the global bovine serum albumin market's growth include its vital role in cell culture and various biochemical assays, its use as a stabilizer in a variety of diagnostic and therapeutic products, and its increasing demand in the pharmaceutical and biotechnology sectors. BSA serves as a critical component in cell culture media, providing essential nutrients, growth factors, and buffering capacity, thereby facilitating cell growth and protein production, making it indispensable in bioprocessing.

Key Market Drivers

Growing Biopharmaceutical Industry

The rapid expansion of the biopharmaceutical industry has significantly contributed to the growth of the global bovine serum albumin (BSA) market. This burgeoning sector, driven by the development of biologics such as monoclonal antibodies, vaccines, and gene therapies, heavily relies on BSA for its unique properties and functionalities. BSA serves as a stabilizing agent during the production of biopharmaceuticals, which are complex and fragile molecules. Its ability to protect these sensitive molecules from denaturation and aggregation is crucial for ensuring the safety and efficacy of the final drug products.

The biopharmaceutical industry's increasing demand for BSA is rooted in several factors. First, the biologics market has experienced remarkable growth due to the effectiveness of these therapies in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. As more biologics enter the market and new therapies are developed, the demand for BSA as a stabilizing and protecting agent in their production processes rises correspondingly.

Key Market Challenges

Ethical Concerns and Alternative Sources

One of the primary challenges facing the BSA market is the growing ethical concern surrounding the use of bovine-derived products. The extraction of BSA from cow's blood serum is associated with ethical dilemmas, as it raises questions about the welfare of animals involved in the process. Cows may undergo invasive procedures to collect serum, raising concerns about cruelty and the treatment of these animals. In response to these concerns, consumers, organizations, and researchers are advocating for more ethical practices in the production of BSA and seeking alternatives that do not involve animal exploitation. For instance, according to a July 2022 report from the Centers for Disease Control and Prevention, six in ten Americans have at least one chronic condition, including stroke, heart disease, cancer, or diabetes. The increasing prevalence of chronic illnesses and the growing demand for personalized medicine are anticipated to drive the demand for bovine serum albumin in the region.

The ethical concerns surrounding bovine-derived BSA have driven the exploration of alternative sources of albumin. Several promising alternatives have emerged, each aiming to address ethical, sustainability, and safety issues. Two notable alternatives are recombinant albumin and plant-based albumin.

Key Market Trends

Expansion of Cell Culture Applications

The expansion of cell culture applications is a key driver boosting the global bovine serum albumin (BSA) market. Cell culture techniques have gained widespread adoption in academic research, biotechnology, and the pharmaceutical industry. BSA, derived from cow's blood serum, is an indispensable component in cell culture media, providing essential nutrients, growth factors, and buffering capacity that are critical for cell growth and protein production.

Researchers and manufacturers are increasingly relying on cell culture to propagate cells for various applications, such as drug development, vaccine production, and regenerative medicine. The ability to create a controlled environment that supports cell growth and replication is essential for the development of advanced therapies and bioprocessing. BSA plays a pivotal role in these processes, ensuring the optimal conditions for cell growth, enhancing productivity, and improving the reproducibility of experiments.

Key Market Players

• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc (U.S.)
• Merck KGAA (Germany)
• Itoham Yonekyu Holdings Inc (Japan)
• Proliant Biologicals (U.S.)
• Kraeber & Co Gmbh (Germany)
• Rockland Immunochemicals Inc (U.S.)
• Rocky mountain biologicals (U.S.)
• BelHealth investment partners, LLC (U.S.)
• Bio-Techne Corporation (U.S.)

Report Scope:

In this report, the Global Bovine Serum Albumin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bovine Serum Albumin Market, By Product:

• Human Serum Albumin
• Bovine Albumin
• Recombinant Serum Albumin

Bovine Serum Albumin Market, By Application:

• Therapeutic
• Drug Delivery
• Culture Media
• Vaccine Ingredient
• Others

Bovine Serum Albumin Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bovine Serum Albumin Market.

Available Customizations:

Global Bovine Serum Albumin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bovine Serum Albumin Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin)
  • 4.2.2. By Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient, Others)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By Region

5. Asia Pacific Bovine Serum Albumin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Application
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Bovine Serum Albumin Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By Application
  • 5.3.2. India Bovine Serum Albumin Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By Application
  • 5.3.3. Australia Bovine Serum Albumin Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By Application
  • 5.3.4. Japan Bovine Serum Albumin Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By Application
  • 5.3.5. South Korea Bovine Serum Albumin Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By Application

6. Europe Bovine Serum Albumin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Bovine Serum Albumin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Germany Bovine Serum Albumin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Spain Bovine Serum Albumin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
  • 6.3.4. Italy Bovine Serum Albumin Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Application
  • 6.3.5. United Kingdom Bovine Serum Albumin Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Application

7. North America Bovine Serum Albumin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Bovine Serum Albumin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. Mexico Bovine Serum Albumin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. Canada Bovine Serum Albumin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application

8. South America Bovine Serum Albumin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Bovine Serum Albumin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. Argentina Bovine Serum Albumin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Colombia Bovine Serum Albumin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application

9. Middle East and Africa Bovine Serum Albumin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Bovine Serum Albumin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Saudi Arabia Bovine Serum Albumin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. UAE Bovine Serum Albumin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Bovine Serum Albumin Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Products
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Bio-Rad Laboratories, Inc (U.S.)
• 14.3. Merck KGAA (Germany)
• 14.4. Itoham Yonekyu Holdings Inc (Japan)
• 14.5. Proliant Biologicals (U.S.)
• 14.6. Kraeber & Co Gmbh (Germany)
• 14.7. Rockland Immunochemicals Inc (U.S.)
• 14.8. Rocky mountain biologicals (U.S.)
• 14.9. BelHealth investment partners, LLC (U.S.)
• 14.10. Bio-Techne Corporation (U.S.)

15.Startegic Recommendation

16.About Us & Disclaimer